SOURCE: Stratton Holdings Inc.

August 24, 2009 10:34 ET

Stratton Holdings, Inc. Acquires LymeCLR™ and Company Assets

MOUNTAIN VIEW, CA--(Marketwire - August 24, 2009) - Stratton Holdings, Inc. (PINKSHEETS: STHG) (www.stratton-holdings.com) acquires LymeCLR™, www.lymeclr.com, LymeCLR trademarks and manufacturing and distribution contracts with Universal Health Sciences, Inc. a Sedona, Arizona-based company.

LymeCLR™ is a full spectrum liquid antibiotic advanced immune system supplement for the purposes of increasing and promoting a healthy immune system in turn combating Lyme Disease in an all natural way. Currently customers have the options of purchasing a 21-day trial period for simply the cost of shipping, of purchasing two 16FL ounce bottles at the discounted cost of $89.97, or simply purchasing one 16FL ounce bottle at the cost of $49.97.

LymeCLR™ was created to meet the demand that lyme disease patients have for a prescription alternative. The treatment of Lyme disease is an extremely controversial subject, but the company strongly believes in the all natural route. Based on research done by Universal Health Sciences, Inc. results of LymeCLR™ are fantastic. Success stories can be found at www.lymeclr.com/testimonials.html.

LymeCLR is currently a web-based company that previously was headquartered in Arizona. Its operations will now be moved to Stratton Holdings, Inc. offices. Stratton Holdings, Inc. has appointed Mr. Eric Stratton Racheff as interim CEO of LymeCLR to run the day to day operations for a minimum of three quarters to establish the company and execute the newly formed marketing program. Once ready then the company will hire a new CEO externally. Currently the manufacturing facilities, based in New York City, can produce up to 120 units per day. Currently www.lymeclr.com is receiving roughly 1000 unique visitors per month without any marketing program in place. The company expects to launch the program in the month of September.

When asked of the transaction and the new found relationship with Stratton Holdings, Inc. Anthony Fore of Universal Health Sciences, Inc. had this to say:

"In the Spring of 2008 UHS, Inc. took that first step towards fighting a perilous pandemic: Lyme disease. Since then UHS, Inc. has helped hundreds of patients fight back and win against this terrible disease.

"We feel honored to now hand the baton to Stratton Holdings, Inc. to continue the journey and carry out our mission for a Lyme-free world. From all of my dealings thus far Mr. Eric Stratton Racheff of Stratton Holdings Inc. is a good man, making positive and bold moves that will benefit all of whom he comes in contact with. Eric and his associates at Stratton Holdings, Inc. all have my blessing in bringing this product to greater degrees of public awareness. Good luck and Godspeed."

Future Acquisitions:

The Company wants to inform shareholders that the officers have begun negotiations with another web-based acquisition that will be announced as soon as the terms are agreed upon. The Company expects this to be executed in short order.

More information about Stratton Holdings, Inc. can be found at www.stratton-holdings.com

Safe Harbor Statement: The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors.

Contact Information